IDL-2965: a selective, highly potent, clinical-stage integrin antagonist for treatment of non-alcoholic steatohepatitisKarl Kossen, Caralee Schaefer,Sharlene Lim, Marshall Michener, Dave Griggs,Peter Ruminski,Ramachandran Radhakrishnan, Christopher Rubino, Tonya Marmon, Ari Gershman, Roxann Hanning, Renee Jones,Watiri Kamau-Kelley,Scott SeiwertJournal of Hepatology（2020）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
